Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network

Area of Science:

• Ophthalmology
• Endocrinology
• Molecular Biology

Background:

• Diabetic retinopathy (DR) is a major cause of vision loss and blindness globally, linked to diabetes mellitus (DM).
• Inflammation is a known factor in DR development and progression.
• Emerging evidence points to non-coding RNAs, particularly long non-coding RNAs (lncRNAs), as key players in diabetes-related complications.

Purpose of the Study:

• To review the role of inflammatory mediators and transcription factors in DR.
• To elucidate the critical roles of lncRNAs in DR and associated inflammation.
• To discuss the implications of lncRNAs in epigenetic mechanisms contributing to DR inflammation.

Main Methods:

• Literature review focusing on inflammatory pathways in DR.
• Analysis of studies investigating lncRNA expression and function in diabetes and DR.
• Exploration of epigenetic mechanisms involving lncRNAs in DR pathogenesis.

Main Results:

• Key inflammatory mediators and transcription factors contributing to DR have been identified.
• Aberrant expression of lncRNAs is observed in diabetes and DR.
• lncRNAs modulate gene expression at multiple levels, influencing inflammation in DR.

Conclusions:

• lncRNAs represent a significant factor in the development and progression of diabetic retinopathy.
• Understanding lncRNA-mediated epigenetic regulation offers potential therapeutic targets for DR.
• Further research into lncRNAs and their role in DR inflammation is warranted.